Clinical Trials in Czechia

• An Open-Label Extension to Study the Long-Term Effect of Dexpramipexole in Participants with Severe Eosinophilic Asthma (EXHALE-5) Under evaluation
  2024-510810-33-00 Phase III Severe eosinophilic asthma Areteia Therapeutics Inc.
• A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/… Not authorised
  2022-500410-26-00 Phase III Cystic Fibrosis University Medical Center Utrecht
• A phase III, randomised, double-blind, multicentre study comparing the efficacy, safety, and immunogenicity of proposed tocilizumab biosimil… Not authorised
  2022-501361-44-00 Phase III Adult patients of either gender with active moderate to seve… Dr. Reddy's Laboratories Limited
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into… Not authorised
  2022-501644-15-00 Phase II Mild Cognitive Impairment due to Alzheimer's Disease Alzheim… Biogen Idec Research Limited
• A seamless, phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without ext… Not authorised
  2022-502877-41-00 Phase I/II Pulmonary sarcoidosis with or without extrapulmonary manifes… Xentria Inc.
• Efficacy and Safety of ANB032 in the Treatment of Subjects with Atopic Dermatitis Not authorised
  2023-503522-40-00 Phase II Atopic Dermatitis Anaptysbio Inc.
• Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis Not authorised
  2023-503634-50-00 Phase III Anemia in patients with chronic kidney disease on dialysis Genexine Inc.
• A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3) Not authorised
  2023-503693-20-00 Phase III Severe eosinophilic asthma Areteia Therapeutics Inc.
• A Study Providing Continued Access to Treatment in Patients with a Neurological Disease Previously Enrolled in a Genentech and/or F. Hoffman… Not authorised
  2023-507633-21-00 Phase III Neurological Disease F. Hoffmann-La Roche AG
• A PHASE III OPEN LABEL STUDY CONTROLLED BY VITAMIN D3 SUPPLEMENTATION AND THE DIFFERENCES BETWEEN YOUNG ADULTS AND SENIOR POPULATION Not authorised
  2024-511889-36-01 Phase III Healthy population Fakultni Nemocnice Plzen
• Study to Evaluate the Efficacy and Safety of ATI-045 in Atopic Dermatitis Not authorised
  2024-520302-19-00 Phase II Atopic dermatitis Aclaris Therapeutics Inc.
• A one-year study to assess if Xanomeline/Trospium (XT) can improve cognitive function in adults living with schizophrenia. Not authorised
  2025-523060-20-00 Phase III Schizophrenia European Group for Research in Schizophrenia Stichting
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown
  2022-502779-40-99 Phase III Primary prevention of atherosclerotic cardiovascular disease… Novartis Pharma AG
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 Phase III Ulcerative colitis Merck Sharp & Dohme LLC
• Safety of stem cells in treatmemt of retinal diseases. Pending
  2023-503573-38-00 Phase I (Other) Retinal degenerative diseases Bioinova a.s.
• The effect of semaglutide therapy on hepatic fat content and on the acute response of liver fat to high-fat load Pending
  2023-504988-16-00 Phase III Obesity Institut Klinicke A Experimentalni Mediciny
• A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sa… Pending
  2023-507590-18-00 Phase II Pulmonary sarcoidosis with or without extrapulmonary manifes… Xentria Inc.
• A study evaluating the safety, tolerability, pharmacokinetics, and activity of RO7566802 given alone and in combination with atezolizumab in… Pending
  2023-509266-38-00 Phase I Locally Advanced or Metastatic Solid Tumors Genentech Inc.
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 Phase III Relapsed Acute Lymphoblastic Leukemia (ALL) Charite Universitaetsmedizin Berlin KöR
• A Phase II Open Label Study of Brentuximab Vedotin in Combination with CHEP in Patients with Previously Untreated CD30-expressing Peripheral… Pending
  2024-511567-28-01 Phase II Cancer Kooperativni Lymfomova Skupina z.s.
• Efficacy of combined treatment by autologous cell therapy and percutaneous transluminal angioplasty (PTA) versus the treatment by isolated P… Pending
  2024-512873-29-00 Phase II chronic limb-threatening ischemia Institute For Clinical And Experimental Medicine
• SIOP PNET 5 medulloblastoma Pending
  2024-513724-42-00 Phase II/III Medulloblastoma University Medical Center Hamburg-Eppendorf
• A study to find an efficacious and safe dose of CHF10067 (zampilimab) in participants with idiopathic pulmonary fibrosis Pending
  2024-514246-37-00 Phase II Idiopathic pulmonary fibrosis (IPF) Chiesi Farmaceutici S.p.A.
• A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of PPV-06 Active Immunotherapy… Pending
  2024-514388-24-00 Phase II Knee osteoarthritis Peptinov

Showing 1–24 of 1,510 trials